Effects of low-dose dopamine on ventilation in patients with chronic obstructive pulmonary disease

Authors: Ciarka, A.; Rimacchi, R.; Vincent, J.-L.; Velez-Roa, S.; Dumonceaux, M.; Leeman, M.; van de Borne, P.

Source: European Journal of Clinical Investigation, Volume 34, Number 7, July 2004 , pp. 508-512(5)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Background 

Dopamine plays an important role in the regulation of respiration and low-dose dopamine infusion is associated with a decreased respiratory drive response to hypoxia in animals and humans. The effects of dopamine on ventilation in patients with chronic obstructive pulmonary disease (COPD) is unknown. We tested the hypothesis that dopamine inhibits ventilation in patients with COPD. Materials and methods 

In a double-blinded, cross-over, placebo-controlled, randomized study we studied nine patients with decompensated COPD, ventilated in the pressure support mode in the intensive care unit (ICU) and five ambulatory patients with stable COPD. All patients received 5 µg kg−1 min−1 of dopamine or an equivalent volume of 5% glucose solution. Results 

In the mechanically ventilated COPD patients, there was no difference in the effects of dopamine compared with placebo on blood pressure, heart rate, minute ventilation (−0·5 ± 1·1 vs. −0·2 ± 0·9 L min−1, P = 0·46, respectively), respiratory rate (−0·4 ± 2·7 vs. −0·3 ± 2·1 min−1, P = 0·96), PaO2 (−5 ± 4 vs. −5 ± 10 mmHg, P = 0·90, respectively), or PaCO2 (−0·7 ± 1·4 vs. −1·0 ± 3·4 mmHg, P = 0·83, respectively). In spontaneously breathing stable patients, dopamine increased systolic blood pressure (P = 0·02) but did not influence other haemodynamic and respiratory variables. Conclusion 

Although low-dose dopamine has been shown to depress ventilation in a variety of conditions, it does not compromise ventilation in COPD patients either breathing spontaneously or when weaned using pressure support ventilation.

Eur J Clin Invest 2004; 34 (7): 508 -512

Keywords: Chemoreflex; COPD; dopamine

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-2362.2004.01375.x

Affiliations: 1: Erasme Hospital, Brussels, Belgium

Publication date: 2004-07-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page